One 1994 topical trial in one specific ulcer population is a data point, not a general claim, and the product it studied was never approved
One significant contribution was made by Hyman Zimmerman in the 1960s, who observed that patients exhibiting hepatocellular DILI alongside jaundice had a notably elevated risk (between 10 and 50%) of progressing to acute liver failureduring a time when liver transplantation was not yet an option
From the present review, it is evident that small peptides exert towards oral cells and tissues an antitumor activity through apoptosis or selective necrosis of cell lines specifically associated with oral squamous cell carcinoma, an antimicrobial function by maintaining the balance of the oral microbiome, an immunomodulatory function through up and down-regulation of important genes involved in immunoregulatory gene cascades, and finally a cell differentiation function towards major stem cells in the oral cavity, even in absence of growth factors [21, 27,28,29,30,31, 34, 35]
The combination lacks specific safety and efficacy data and should be investigated with appropriate caution in controlled research settings
Discount applied
